AIDS Clinical Trials Group 5197: A Placebo‐Controlled Trial of Immunization of HIV‐1–Infected Persons with a Replication‐Deficient Adenovirus Type 5 Vaccine Expressing the HIV‐1 Core Protein-Reference-Cited by-同舟云学术

AIDS Clinical Trials Group 5197: A Placebo‐Controlled Trial of Immunization of HIV‐1–Infected Persons with a Replication‐Deficient Adenovirus Type 5 Vaccine Expressing the HIV‐1 Core Protein

Published:2010-09 Issue:5 Volume:202 Page:705-716
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Schooley Robert T.,Spritzler John,Wang Hongying,Lederman Michael M.,Havlir Diane,Kuritzkes Daniel R.,Pollard Richard,Battaglia Cathy,Robertson Michael,Mehrotra Devan,Casimiro Danilo,Cox Kara,Schock Barbara

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/202/5/705/18062516/202-5-705.pdf

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion;PLOS Pathogens;2024-07-29

2. PD-1 blockade enhances HIV-1 vaccine-induced CD8⁺ T-cell responses in PWH early ART-treated;2024-07-06

3. Definition of Virological Endpoints Improving the Design of Human Immunodeficiency Virus (HIV) Cure Strategies Using Analytical Antiretroviral Treatment Interruption;Clinical Infectious Diseases;2024-05-31

4. Role of homologous recombination/recombineering on human adenovirus genome engineering: Not the only but the most competent solution;Engineering Microbiology;2024-03

5. Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure;Journal of Translational Medicine;2023-11-07